本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

195.92
-8.9400-4.36%
盤後196.500.5800+0.30%17:50 EDT
成交量:303.67萬
成交額:6.00億
市值:419.93億
市盈率:-21.96
高:205.15
開:204.84
低:193.58
收:204.86
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:2.55
換手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.11
市盈率(LYR):-32.93

資料載入中...

2023/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/10

重要事件披露

8-K - Current report
2022/12/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report
2022/09/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/01

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/22

重要事件披露

8-K - Current report
2022/07/13

重要事件披露

8-K - Current report
2022/06/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals